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During late mitosis and the early G1 phase, the origins of replication are licensed by binding to double hexamers of MCM2–7. 
In this study, we investigated how licensing and proliferative commitment are coupled in the epithelium of the small 
intestine. We developed a method for identifying cells in intact tissue containing DNA-bound MCM2–7. Interphase cells 
above the transit-amplifying compartment had no DNA-bound MCM2–7, but still expressed the MCM2–7 protein, suggesting 
that licensing is inhibited immediately upon differentiation. Strikingly, we found most proliferative Lgr5+ stem cells are 
in an unlicensed state. This suggests that the elongated cell–cycle of intestinal stem cells is caused by an increased G1 
length, characterized by dormant periods with unlicensed origins. Significantly, the unlicensed state is lost in Apc-mutant 
epithelium, which lacks a functional restriction point, causing licensing immediately upon G1 entry. We propose that the 
unlicensed G1 phase of intestinal stem cells creates a temporal window when proliferative fate decisions can be made.
Lgr5+ intestinal stem cells reside in an unlicensed G1 
phase
Thomas D. Carroll1, Ian P. Newton1, Yu Chen1, J. Julian Blow2, and Inke Näthke1
Introduction
Cell division is necessary for homeostasis of  adult tissue. It 
allows for the replacement of aged or damaged cells and pro-
vides specialized cells critical for tissue function. The deci-
sion to proliferate is crucial, especially for stem cells, which 
produce daughter cells that either maintain the fate of a stem 
cell or differentiate to produce specialized cells. The rapidly 
renewing intestinal epithelium replenishes its cellular con-
tent every 4–5 d. This high turnover rate is maintained primar-
ily by Lgr5+ intestinal stem cells in the crypt base, which are 
thought to be continually proliferative (Basak et al., 2014) as 
confirmed by proteomic and transcriptomic analysis (Muñoz 
et al., 2012). There is also a quiescent stem cell population that 
can reengage with the cell cycle to repopulate the Lgr5+ cell 
population if  it becomes depleted. These quiescent stem cells 
reside at the +4 position and constitute a subset of Lgr5+ cells 
and are immature, secretory-lineage precursors (Buczacki et 
al., 2013). Lgr5+ stem cells can divide to form transit-amplify-
ing (TA) cells, which undergo several rounds of cell division 
before differentiating and losing proliferative competency 
(Potten and Loeffler, 1990).
How proliferative-fate decisions are governed in stem and TA 
cells is not understood. Lineage-tracing studies suggest that in 
homeostatic intestinal tissue only five to seven intestinal stem 
cells are “active” of the 12–16 Lgr5+ cells present in the crypt base 
(Kozar et al., 2013; Baker et al., 2014). Interestingly, Lgr5+ cells 
have a significantly longer cell cycle than do TA cells (Schepers et 
al., 2011). The functional significance of the prolonged cell-cycle 
time on Lgr5+ stem cells is currently unknown, but it suggests 
an active regulation of cell-cycle progression and proliferative 
fate commitment.
Proliferative-fate decisions are typically visualized by detect-
ing markers that are present in all cell-cycle phases, which 
only distinguishes proliferative from quiescent cells. Visualiz-
ing the incorporation of labeled nucleosides, such as BrdU or 
5-ethynyl-2′-deoxyuridine (EdU), marks cells in the S phase. 
The limitation of these methods is that they cannot discrimi-
nate early proliferative-fate decisions made during the preced-
ing mitosis or during the early stages of G1. DNA replication 
in the S phase depends on origin licensing, which involves the 
regulated loading of minichromosome maintenance (MCM) 2–7 
complexes onto origins of DNA replication (Blow and Hodgson, 
2002; Champeris Tsaniras et al., 2014). During the S phase, DNA-
bound MCM2–7 hexamers are activated to form the catalytic core 
of the DNA helicase as part of the CMG (Cdc45, MCM2–7, GINS) 
complex (Moyer et al., 2006; Ilves et al., 2010; Makarova et al., 
2012). Replication licensing is thought to occur from late mitosis 
and throughout the G1 phase until passage through the restric-
tion point (Dimitrova et al., 2002; Namdar and Kearsey, 2006; 
Symeonidou et al., 2013; Håland et al., 2015). Correspondingly, 
insufficient origin licensing directly limits the ability to progress 
past the restriction point causing cell-cycle arrest (Shreeram et 
al., 2002; Liu et al., 2009; Alver et al., 2014). When functional, 
this licensing-checkpoint can delay the S phase if an insufficient 
amount of origins have been licensed.
When cells enter the G0 phase, MCM2–7 proteins are 
down-regulated and degraded, primarily via E2F-mediated 
© 2018 Carroll et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https:// creativecommons .org/ licenses/ by/ 4 .0/ ).
1Cell and Developmental Biology, University of Dundee, Dundee, Scotland, UK; 2Centre for Gene Regulation and Expression, University of Dundee, Dundee, Scotland, UK.
Correspondence to Julian J. Blow: j.j.blow@ dundee .ac .uk; Inke Näthke: i.s.nathke@ dundee .ac .uk. 
on April 6, 2018jcb.rupress.org Downloaded from 
http://doi.org/10.1083/jcb.201708023Published Online: 29 March, 2018 | Supp Info: 
Carroll et al. 
Lgr5+ intestinal stem cells reside in an unlicensed G1 phase
Journal of Cell Biology
https://doi.org/10.1083/jcb.201708023
2
transcriptional control of MCM2–7, Cdc6, and Cdt1 (Leone et 
al., 1998; Williams et al., 1998; Ohtani et al., 1999). This pre-
vents terminally differentiated cells from reentering the cell 
cycle. In mammalian cells, artificial induction of quiescence 
through contact inhibition leads to gradual down-regulation of 
Cdc6 and MCM2–7 over several days (Kingsbury et al., 2005). 
These features have led to the suggestion that quiescence can 
be defined by an unlicensed state (Blow and Hodgson, 2002). 
Equally, the licensing status can define a different restriction 
point that signals proliferative-fate commitment at the end of 
mitosis and in early G1, independent of the retinoblast protein 
(Rb)/E2F restriction point.
The dynamics of replication licensing in the intricate cellu-
lar hierarchy of a complex, rapidly renewing adult tissue is not 
understood. Therefore, we investigated the licensing system in 
the intestinal epithelium, aiming to understand dynamics of 
early cell-cycle commitment in stem and TA cells and during ter-
minal differentiation.
Results
Mcm2 expression declines along the crypt–villus axis
Because of their abundance and their strong conservation and 
association with the core DNA replication process, the presence 
of MCM2–7 proteins is commonly used to establish prolifer-
ative capacity in tissues, similar to Ki67 or PCNA (Williams et 
al., 1998; Stoeber et al., 2001; Gonzalez et al., 2005; Juríková et 
al., 2016). Usually, terminally differentiated cells in mammalian 
tissues do not contain MCM2–7 (Todorov et al., 1998; Stoeber et 
al., 2001; Eward et al., 2004). To establish the overall MCM2–7 
protein abundance along intestinal crypts, we first examined the 
expression of MCM2–7 proteins in the epithelium of the small 
intestines of adult murine by high-resolution immunofluores-
cence microscopy. We focused on Mcm2 as a surrogate for all 
the members of the MCM2–7 complex, based on their similar 
function and localization. However, we repeated a subset of the 
experiments using an antibody to Mcm4, which is less effective 
in detecting endogenous proteins. Nonetheless, in all cases, the 
results were identical.
Consistent with previous studies, Mcm2 was highly expressed 
in both murine and human intestinal epithelium. Mcm2 was 
highly expressed in intestinal crypts (Fig.  1  A) and declined 
gradually along the crypt–villus axis (Fig. 1 B) but persisted in a 
few cells in the villus compartment (Fig. 1 D). Mcm2 was nuclear 
in interphase cells but cytoplasmic during mitosis (Fig.  1  C). 
Although most intestinal crypt cells expressed Mcm2, at the 
crypt base, Mcm2+ and Mcm2− cells were interspersed (Fig. 1, 
A and D), consistent with previous studies (Pruitt et al., 2010). 
This pattern is reminiscent of the alternating arrangement of 
Lgr5+ stem cells and Paneth cells at the crypt base (Barker et al., 
2007). Lgr5+ stem cells express Ki67 and are continually pro-
liferative whereas Paneth cells are fully differentiated and are 
Ki67− (Basak et al., 2014). As expected, Mcm2 was expressed in 
all Lgr5+ stem cells, and there was a strong correlation between 
Mcm2 and Lgr5 expression (Fig. 1 E). This is consistent with the 
idea that Lgr5Hi stem cells are the main proliferative stem cells 
in the intestinal crypt. Staining with Ulex europaeus agglutinin 
(UEA) I demonstrated that most Mcm2− cells in the crypt base are 
UEA+ Paneth cells (Fig. 1 F).
Normally, MCM2–7 expression is lost in terminally differenti-
ated cells (Williams et al., 1998, 2004; Stoeber et al., 2001; Eward 
et al., 2004). The loss of expression has been suggested as a major 
contributor to the proliferation-differentiation switch in vivo. 
To test this idea, we measured the Mcm2 content of young and 
mature secretory cells in intestinal crypts and villi (Fig. 1, G and 
H). There was differential expression of Mcm2 in distinct secre-
tory lineages. Many mature secretory cells, including Paneth, 
goblet, and enteroendocrine cells, were Mcm2−, consistent with 
their differentiation status and long life span in the epithelium 
(van der Flier and Clevers, 2009). We detected a few UEA+ Mcm2+ 
cells in the intestinal crypts (Fig. 1 G). If we assume that Mcm2 
expression declines slowly after terminal differentiation, the 
presence of Mcm2 in UEA+ secretory cells could reflect their 
immaturity. Consistently, Mcm2 expression in UEA+ cells in the 
crypts was significantly greater than in the villi (Fig. 1 H), sup-
porting the idea that MCM2–7 are gradually lost upon terminal 
differentiation. Because MCM2–7 are highly abundant and have 
a long (>24 h) half-life (Musahl et al., 1998), it likely that, after 
cells differentiate, their MCM2–7 content declines at a slow rate, 
explaining why Mcm2 persists in the villus compartment.
Visualization of DNA replication licensing in vivo
MCM2–7 exist in three states: as hexamers, free in the nucleop-
lasm; as double hexamers, bound to DNA during late mitosis and 
G1 and S phases; or as CMG complexes, at replication forks during 
the S phase (Evrin et al., 2009; Remus et al., 2009; Gambus et 
al., 2011). To distinguish between DNA-bound and soluble forms, 
we developed a protocol involving a brief extraction of isolated 
crypts with nonionic detergent to remove soluble MCM2–7. The 
remaining Mcm2 should mark cells whose origins are licensed 
for replication. Extraction did not visibly affect intestinal crypt 
integrity but made them more opaque compared with unex-
tracted tissue (Fig. 2 A). Most cells in unextracted crypts were 
Mcm2+ (Fig. 2 B, Total) similar to tissue sections and mirroring 
the ubiquitous expression of Ki67 along the crypt axis. After 
extraction, most of the Mcm2 content in cells was lost (Fig. 2 B, 
Licensed), with only 10–30% of cells maintaining high levels of 
Mcm2 (Fig.  2  C). After extraction, Mcm2+ was not present in 
mitotic cells expressing phosphorylated histone H3, confirming 
the extraction procedure successfully removed non–DNA-bound 
MCM2–7 proteins (Fig. 2 D).
We used flow cytometry to measure MCM2–7 content more 
directly and to further confirm the effectiveness of the extraction 
procedure. Whereas most isolated epithelial cells expressed 
Mcm2 that persisted throughout the cell cycle, extraction revealed 
a distinct profile of Mcm-containing cells in the crypts (Fig. 2 E). 
These profiles are consistent with those reported for cultured cell 
lines (Friedrich et al., 2005; Håland et al., 2015; Moreno et al., 
2016; Matson et al., 2017). Mcm2 is present throughout the cell 
cycle (Fig. 2 E, Unextracted), but extraction shows that it binds to 
DNA throughout the G1 phase, reaching a maximum level before 
cells enter the S phase, and is subsequently displaced from the 
DNA during S phase. This behavior, which matches the known 
cell-cycle behavior of MCM2–7, confirms the efficiency of our 
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Figure 1. Mcm2 is expressed ubiquitously along the crypt–villus axis and declines slowly as cells differentiate. (A) Sections of normal human (top) 
and mouse (bottom) small intestine were stained with phalloidin (green) and an antibody against Mcm2 (red). Bars, 200 µm. (B) Mean Mcm2 intensities for 
segmented nuclei were plotted along the crypt–villus axis for human (left) and mouse (right) tissues. Locations of the crypt and villus domains are indicated. 
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extraction protocol. An antibody against Mcm4 produced sim-
ilar results (data not shown). We observed that most cells with 
G1 DNA content appeared to be unlicensed, having a DNA-bound 
Mcm2 content similar to G2/M cells (Fig. 2, E and E′). This is sub-
stantially different from typical profiles observed in cultured 
cells lines in which most G1 cells are fully licensed (Friedrich et 
al., 2005; Håland et al., 2015; Moreno et al., 2016; Matson et al., 
2017). Similar results were observed in cells isolated from intes-
tinal organoids (Fig. 2, F and G).
Licensing status and cell-cycle progression along the 
crypt–villus axis
Cell-cycle dynamics of intestinal stem and progenitor cells are 
highly heterogeneous (Pruitt et al., 2010). Most of the Lgr5+ 
stem cells are considered to be continually proliferative but with 
a much longer cell cycle than TA progenitor cells, which are most 
commonly found in the S phase (Schepers et al., 2011). To inves-
tigate proliferative-fate decisions of the intestinal epithelial cells, 
we used our MCM2–7 extraction in crypts in which S phase cells 
were labeled in vivo with the nucleoside analogue EdU. We then 
used image analysis software to correlate Mcm2 content with 
cell-cycle stage along the crypt–villus axis (Fig. S1, A–F). This 
allowed quantification of licensing in relation to the cell cycle 
and 3D spatial information.
Fig. 3 A shows tissue labeled in vivo with a 1-h EdU pulse, fol-
lowed by extraction of soluble MCM2–7. As expected, most cells 
in the TA compartment were labeled with EdU, suggesting that 
most cells were in the S phase, consistent with early studies with 
BrdU and [3H]thymidine labeling (Chwalinski and Potten, 1987). 
The patterns of replication foci were consistent with the reported 
S phase replication timing program (Rhind and Gilbert, 2013). 
Typically, all licensed cells had intense nuclear Mcm2 staining. 
Some cells completely lacked Mcm2 and EdU labeling, suggesting 
they were in either in G0, very early G1, or G2 phase. Some cells 
were labeled with both Mcm2 and EdU. These double-labeled 
cells typically showed patterns of EdU labeling consistent with 
early to mid S phase and Mcm2 labeling of DNA compartments 
expected to replicate later in S phase. This relationship has been 
observed in tissue-culture cells (Krude et al., 1996) and is consis-
tent with the idea that DNA-bound MCM2–7 are displaced from 
chromosomal domains as replication is completed. Cells with 
late S phase patterns of EdU labeling had little or no detectable 
Mcm2, consistent with the displacement of most MCM2–7 by 
the end of the S phase. We also measured nuclear volume, which 
increases during S and G2 phases. This showed that nuclear vol-
ume increased up to twofold in cells classified as S and late S/G2 
phases by Mcm2 and EdU staining (Fig. 3 B). This confirms our 
cell-cycle assignment and also suggests that most Mcm2− cells are 
in G0 or G1, rather than in G2, phase.
The combination of concurrently labeling DNA-bound Mcm2 
and EdU showed a clear correlation between cell position and 
cell-cycle stage. As noted previously, Mcm2 is expressed in 
cells throughout the crypt (Fig. 3, C and D). At the base of the 
crypt, unlicensed cells predominate (Fig. 3, C and E). At increas-
ing distances from the crypt base, there is a successive rise in 
licensed G1, early/mid S, and then late S/G2 phase cells. Further 
up the crypt, at the end of the TA compartment, these cell-cycle 
stages decline in reverse order, until unlicensed cells again pre-
dominate. This suggests that there is a coordinated progression 
through the cell-division cycle as cells enter, then leave, the TA 
compartment. This was also observed as a field effect with many 
neighboring cells showing similar replication patterns (Fig. S2, 
A and B; and Video 1).
Terminal differentiation is associated with a binary 
licensing decision
At the terminal boundary of the TA compartment, most cells were 
unlicensed and had no DNA-bound Mcm2 (Fig. 3, C and E). Simi-
larly, there were no licensed G1 cells beyond the TA compartment, 
as defined by incorporation of EdU (Fig. 3 F). However, total Mcm2 
expression extended significantly beyond the last cells with DNA-
bound Mcm2 or incorporated EdU (Fig. 3, C, D, and F). The distribu-
tion of total Mcm2 expression corresponded to the zone in which 
cells express Ki67 (Fig. S3). Although Mcm2 and Ki67 expression 
persists beyond the TA compartment, licensing does not occur in 
this area. This suggests that differentiation is not governed by a 
gradual reduction in total MCM2–7 levels but is a binary decision, 
and licensing is abolished immediately after the final mitosis pre-
ceding differentiation. To further examine this, we marked the 
terminally differentiated zone by a 1-h EdU pulse, followed by a 
16-h chase (Fig. 3, G and H). After 16 h, most of the distal end of the 
TA compartment became labeled with EdU. All labeled nuclei in 
this area were significantly smaller than EdU+ cells at the proximal 
end of the TA compartment (unpublished data), suggestive of their 
differentiation status. Importantly, the EdU+-differentiated cells at 
the distal end of the TA compartment lacked DNA-bound Mcm2, 
supporting our suggestion that licensing is inhibited immediately 
at terminal differentiation.
(C) An intestinal crypt stained with Hoechst (blue), phalloidin (green), and an antibody against Mcm2 (red). Individual cells in interphase and mitosis (metaphase 
and cytokinesis) are outlined by dashed white lines. Bars: (left) 50 µm; (middle and right) 10 µm. (D) Maximum-intensity projections of whole-mount intestinal 
tissue revealing intestinal crypts and villi (left; Bars, 200 µm). Individual X–Y sections are also shown to reveal the epithelium (right; Bars: [top] 50 µm; [bottom] 
100 µm). Tissue was stained with phalloidin (green), Hoechst (blue), and an antibody against Mcm2 (red). The alternating pattern of Mcm2+ (green stars) and 
Mcm2− (orange stars) in the crypt base is highlighted. (E) Images of Lgr5–GFP stem cells (green; top) costained with an Mcm2 antibody (red). Bars, 10 µm. The 
correlation (Pearson’s correlation R = 0.81, P < 0.0001) between mean Mcm2 and Lgr5–GFP intensities for Lgr5–GFP+ cells (n = 69), normalized to the maximum 
intensity for an individual crypt, is shown. (F) Images of UEA+ Paneth cells (top) costained with an Mcm2 antibody (red) and UEA (green). Bars, 10 µm. Mean 
Mcm2 intensity for segmented nuclei of UEA+ Paneth cells was compared with interphase cells (right). (G) Mcm2 (green) and UEA (red) expression in subsets of 
UEA+ cells in crypt and villus domains. Bars, 10 µm. UEA+ cells at the crypt base represent Paneth cells. (H) Quantification of mean Mcm2 intensity in individual 
UEA+ cell populations. UEA+ cells in the crypt base (Paneth cells, n = 224), in the upper crypt compartment (crypt, n = 132) and in the villus compartment (villus, 
n = 225) were identified manually, and the nuclear Mcm2 intensity was determined for individual cells (all cells, n = 33,736). There was a significant difference 
between UEA+ cells in the crypt and villus compartments (t test,****, P < 0.0001).
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Most intestinal stem cells spend most of their time in the G1 
phase in an unlicensed state
Most cells in the crypt base expressed Mcm2, consistent with the 
finding that all Lgr5+ cells express Mcm2, but mature secretory 
cells, such as Paneth cells, do not (Fig. 1, D and E). Surprisingly, 
extraction revealed that only 7–15% of cells were licensed in the 
crypt base (Fig.  3, C and D), with most cells in an unlicensed 
state despite expressing Mcm2. The abundance of licensed cells 
peaked 40–60 µm away from the crypt base, corresponding to 
just above the +4/+5 cell position (Fig. 3, D and E). This suggests 
that most stem cells remained unlicensed. In contrast, most TA 
cells appear to progress rapidly through the cell cycle, and many 
more actively incorporate EdU (Fig. 4 A).
We next confirmed that the unlicensed cells at the crypt base 
were Lgr5+ stem cells. Because it is not possible to identify Lgr5 
in these experiments, because it is extracted along with unbound 
Mcm2, we instead identified Paneth cells by UEA staining and 
considered all UEA− cells in the crypt base as stem cells (Fig. 4 B). 
More than 50% of the UEA− stem cells were in an unlicensed 
state and were not incorporating EdU (Fig. 4 C). Approximately 
Figure 2. Visualizing Mcm2 licensing in intestinal crypts. (A) Representative bright-field images of extracted and unextracted, isolated intestinal crypts. 
Bars, 100 µm. (B) Representative images of isolated crypts stained with antibodies against Mcm2 (red) or Ki67 (purple). Bars, 10 µm. (C) The Mcm2 labeling 
index for unextracted and extracted crypts is significantly different (Means ± SEM, n = 10 crypts; t test, P < 0.0001). (D) Representative intestinal crypts stained 
with Hoechst (blue) and antibodies against Mcm2 (red) and phospho-histone H3 (pH-H3; green). Bars, 10 µm. (E) Representative flow cytometry profiles for 
extracted and unextracted, isolated, crypt epithelial cells showing Mcm2 versus DNA content. Data are representative of 3 independent experiments. (E’) Sug-
gested model of the licensing profile shown in E. Deeply quiescent cells do not express Mcm2 and have a no detectable Mcm2 signal. Cells expressing soluble 
Mcm2 (unlicensed G1) show a similar Mcm2 signal to G2 cells. After a proliferative-fate decision has been made, origins become licensed and cells commit to S 
phase entry. Cells enter S phase after maximal origin licensing (active G1). During the S phase, Mcm proteins are then displaced from DNA during replication. 
(F) Representative images of extracted and unextracted intestinal organoids stained with an antibody against Mcm2 (red). Bars, 10 µm. (G) The Mcm2-labeling 
index for unextracted and extracted organoids. Data are displayed as means ± SEM; n = 3 organoids and shows a significant difference (t test, P < 0.0001).
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Figure 3. The licensing state defines distinct proliferative zones in intestinal crypts. (A) Representative image of an extracted intestinal crypt isolated 
after a 1-h EdU pulse in vivo (green) and stained with Hoechst (blue) and antibodies against Mcm2 (red) and pH H3 (white). Bars: (top) 10 µm; (bottom) 1 µm. 
Costaining shows distinct cell-cycle phases (bottom), licensed cells committed in G1 with Mcm2+ and EdU−; early Mcm2+ and EdU+ to late Mcm2− and EdU+ in 
the S phase, and mitotic cells, pH H3+. Negative cells represent deeply quiescent (G0), terminally differentiated cells or cells in G1 that have not made a prolifer-
ative-fate decision, remaining unlicensed. The crypt base is to the left of the displayed image. (B) Nuclear volume was estimated in cells at the distinct cell-cycle 
phases identified previously: negative (G0/G1/G2, n = 115); G1 licensed Mcm+ and EdU− (n = 38); S phase Mcm+ and EdU+ (n = 24); and late S/G2 Mcm− and EdU+ 
(n = 26). (Top) Representative examples of each cell-cycle phase and the associated 3D rendered nuclei. Bars, 10 µm. The means ± SEM are displayed. There 
was a significant difference in the size of licensed G1, S, and late S/G2 nuclei (t test, P < 0.0001). (C) Representative images of intestinal crypts isolated after 
a 1-h EdU pulse (green) in vivo. Displayed are 3D projections of extracted and unextracted crypts stained with Hoechst (blue) and an antibody against Mcm2 
(red). The crypt base is to the left of the displayed image. (D) Comparison between cells expressing Mcm2 protein and DNA-bound Mcm2 along the crypt– 
villus axis between unextracted (n = 101 crypts) and extracted (n = 109 crypts; taken from 3 mice) cells. Data are displayed as the mean percentage of cells per 
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30–40% of all UEA− cells in the stem cell compartment were in 
an active phase of the cell cycle (licensed G1, S, or G2; Fig. 4 C), 
corresponding to five to six stem cells of the total of 14 present 
(Snippert et al., 2010). This number is similar to the small num-
ber of proposed “working” stem cells in the crypt base (Kozar et 
al., 2013; Baker et al., 2014). Unlicensed cells not incorporating 
EdU (i.e., unlabeled cells in this experiment) could theoretically 
be in either G1 or G2 phase. To distinguish between these pos-
sibilities, we first isolated crypt cells from Lgr5–GFP mice and 
measured both GFP and DNA content. Both Lgr5+ and Lgr5− cell 
populations had a similar cell-cycle profile with most cells hav-
ing two complete sets of chromosomes (2N) DNA content (Fig. 
S2 C). We also examined the nuclear volume of cells at different 
positions along the crypt axis after staining for EdU incorpora-
tion and DNA-bound Mcm2. Most unlicensed cells had a nuclear 
volume similar to that of fully licensed cells in G1 and not cells in 
late S/G2 phase (Fig. S2 D). Together, these results suggest that, 
although they express abundant Mcm2, most intestinal stem 
cells reside in an unlicensed G1 state.
To confirm this conclusion, we flow-sorted unextracted 
Lgr5–GFP+ cells, extracted unbound MCM2–7, and stained the 
cells for Mcm2 and Ki67. Consistent with our previous results, 
most Lgr5+ cells with a 2N DNA content had low levels of DNA-
bound Mcm2 and were in an unlicensed state (Fig. 4 D [i and ii]). 
Importantly, both the licensed and unlicensed cells were Ki67+ 
indicating that they had not withdrawn from the cell-cycle long-
term (Fig. 4 D [ii]).
This unlicensed G1 state—2N DNA content, high Mcm2 
expression, but low levels of DNA-bound Mcm2—could be 
explained by two slightly different scenarios: (1) MCM2–7 are 
loaded onto DNA slowly in Lgr5+ cells, thereby extending G1 
(Schepers et al., 2011; Dalton, 2015); or (2) Most Lgr5+ cells enter 
G1 and remain in an unlicensed state but do not load MCM2–7 
until an active decision is made to commit to cell-cycle progres-
sion and activate the licensing system, at which time, MCM2–7 
proteins are rapidly loaded. In option (1), in which licensing 
is slow, the presence of unlicensed cells simply reflects the 
increased time required to fully license origins, and different 
levels of Mcm2 loading should be equally distributed among G1 
cells. In option (2), however, in which G1 licensing does not occur 
during an early stage, there should be a discrete peak of unli-
censed cells with G1 DNA content, representing cells that have 
withdrawn from the cell cycle, and there would be fewer G1 cells 
and they would be loaded with different amounts of MCM2–7. 
To distinguish between these two possibilities, we used ergo-
dic rate analysis (Kafri et al., 2013; Matson et al., 2017). When 
examining the frequency distribution of DNA-bound Mcm2 in 
Lgr5+ cells with 2N DNA content, we found a discrete peak of 
unlicensed cells (Fig. 4 E), consistent with the second model. To 
confirm these observations, we performed computer modeling 
(see the online supplemental material for source code) in which 
the licensing rate was varied in the presence or absence of an 
initial G1 period when licensing did not occur (Fig. 4 F). With 
no unlicensed G1 period and low licensing rates (Fig. 4 F, left), 
G1 cells were equally distributed across the different degrees 
of licensing. With faster licensing rates and no unlicensed 
G1 period, a distinct peak of fully licensed G1 cells appeared, 
similar to what has been observed in cell lines. Only when an 
unlicensed G1 period was introduced did a distinct peak of unli-
censed G1 cells appear (Fig. 4 F, left). Most of these unlicensed 
Lgr5+ cells express abundant Mcm2 (Fig. 1 D), which suggests 
that their G1 is characterized by a long unlicensed period. This 
may explain why the cell-cycle length of intestinal stem cells is 
significantly longer than it is for TA cells (Schepers et al., 2011).
To further confirm that many intestinal stem cells exist in an 
unlicensed G1 state, we examined the expression of fluorescence 
ubiquitination cell-cycle indicator (FUC CI) reporters as an inde-
pendent indicator of cell-cycle progression. We harvested intes-
tinal tissue from Fucci2aR mice (Mort et al., 2014) and examined 
the expression of the G1-specific hCdt1(30/120) and S/G2/M-spe-
cific hGeminin(1/110) reporters (Fig. S4 A). As expected, many 
TA cells were hGeminin(1/110)+. We also noticed that terminally 
differentiated cells, such as Paneth cells in the stem cell com-
partment, and cells at the tips of villi expressed high levels of 
hCdt1(30/120) (Fig. S4 B) reflecting accumulation of the reporter 
in differentiated cells (Mort et al., 2014). However, we found that 
most Mcm2+ stem cells in the crypt base expressed very low lev-
els of the hCdt1(30/120) reporter, and only a few cells expressed 
high levels (Fig. S4, C and D). In contrast, most TA cells were 
either hGeminin(1/110)high or hCdt1(30/120)low, consistent with 
a short G1 phase. Together, this suggests that stem cells remain in 
a paused, unlicensed G1 state, where they do not rapidly accumu-
late hCdt1(30/120), unlike rapidly proliferating cells.
Embryonic stem cells have been reported to license more rep-
lication origins than neural stem/progenitor cells differentiated 
from them (Ge et al., 2015). To determine whether adult stem and 
non–stem cells in intestinal crypts exhibit such differences, we 
compared the amount of DNA-bound Mcm2 in G1/G0 and early 
S phase Lgr5+ cells with that of Lgr5− cells (Moreno et al., 2016). 
Although most Lgr5+ cells were unlicensed, when they entered 
the S phase, they had approximately twice as much DNA-bound 
Mcm2 as Lgr5− cells had (Fig. 4 G). This is consistent with the idea 
that adult intestinal stem cells license more origins than TA cells 
do and may represent a mechanism to protect genomic integrity.
set distance bin. (E) All cells were divided into four distinct groups based on Mcm2 and EdU intensities. These groups represent distinctive cell-cycle phases 
as defined by their total (unextracted, n = 101 crypts) or licensed (extracted, n = 109 crypts) Mcm2 content: extracted, (1) Unlicensed Mcm2− and EdU−, (2) G1 
licensed Mcm2+ and EdU−, (3) early/mid S phase Mcm2+ and EdU+, and (4) late S/G2 Mcm2− and EdU+. The data are represented as the population means of the 
total cells per distance bin. Means ± SEM; ***, P < 0.001; **, P < 0.01. (F) The distance of the most distal Mcm2+ and EdU+ cells to the crypt base was compared 
in extracted and unextracted crypts. Data were scored manually for 10 representative crypts per condition. Licensed Mcm2+ cells were significantly closer 
to the crypt base than were EdU+ cells (t test, P = 0.0015. Cells expressing Mcm2 protein extended significantly above the last EdU+ cell (t test, P < 0.0003). 
(G) Representative images of crypts isolated 17 h after administration of EdU (green). 3D projections of extracted and unextracted crypts stained with Hoechst 
(blue) and an antibody against Mcm2 (red) are shown. (H) Cells were divided into four distinct groups as in E (n = 51 crypts).
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Figure 4. Intestinal stem cells reside in a paused, unlicensed G1 phase. (A) Quantification of cell-cycle stages for cells in the stem cell (SC) compartment 
(<40 µm from the crypt base) and in the early TA compartment (40–80 µm from the crypt base), as described in Fig. 3 E (n = 49 crypts). (B) Representative 
image of an extracted crypt base isolated 1 h after a pulse of EdU (green) and stained with Hoechst (blue), UEA (red), and antibodies against Mcm2 (white). Bar, 
10 µm. Nuclear morphology and UEA signals were used to distinguish between UEA+ Paneth cells (outlined by dashed lines and nuclei marked with blue stars) 
and UEA− stem cells (situated between outlined Paneth cells, with nuclei marked by red stars). (C) The mean percentage of UEA− stem cells that fall into the 
previously defined cell-cycle bins: unlicensed; G1 licensed; S phase; and S/G2 phase (n = 68 crypts). Displayed are the means ± SEM. (D) Representative flow 
cytometry profiles of isolated Lgr5Hi intestinal stem, showing DNA-bound Mcm2 and DNA content (n = 3 mice; panel i). The 2N (G1) cells of the same population 
are also shown (ii). The respective gated populations for unlicensed G1 (black), licensed (red), S phase (yellow), and G2/M (green) are shown. The Ki67 content of 
the licensed and unlicensed G1 cells are also shown (iii). (E) The frequency distribution of mean DNA-bound Mcm2 intensities for Mcm2+ cells in G1 cells. Shown 
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Intestinal label-retaining cells are in a deep G0 state
Although the intestinal crypt base primarily consists of Lgr5+ stem 
cells, there is also a reserved pool of quiescent stem cells, often 
referred to as “+4 label-retaining cells” (LRCs), reflecting their 
position in the crypt base and their ability to retain nascent DNA 
labels (Potten et al., 2002). These cells are a rare subset of Lgr5+ 
cells and are also secretory precursors (Buczacki et al., 2013). 
To further define the licensing status of these label-retaining, 
intestinal stem cells, we identified UEA− LRCs by expressing 
H2B–GFP (which is incorporated into the chromatin of divid-
ing cells) for 7 d and then chased them for a further 7 d (Roth et 
al., 2012; Buczacki et al., 2013). Labeled cells that did not divide 
during the 7-d chase period contained high levels of H2B–GFP 
(and were, therefore, LRCs), but cells that divided multiple times 
had only low levels of H2B–GFP. LRCs were then distinguished 
from Paneth cells based on UEA staining (Fig. 5 A). After induc-
tion, most cells in the epithelium expressed H2B–GFP (Fig. 5 B 
[i]). After the 7-d chase, H2B–GFP expression was restricted to 
cells near the villus tips, and cells at the crypt base (Fig. 5 B [ii]). 
We could successfully distinguish between Paneth cells and LRCs 
based on UEA staining (Fig. 5 B [ii]). Unlike most Lgr5+ cells, LRCs 
with high levels of GFP–H2B did not express Mcm2 (Fig. 5 C). As 
expected, only non-LRC daughter cells with low levels of H2B–
GFP had DNA-bound Mcm2 (Fig. 5 D). This shows that LRC stem 
cells are in deep G0, unable to license because they do not express 
MCM2–7. In contrast, “active” intestinal stem cells mostly reside 
in an unlicensed G1 state.
Licensing dynamics in intestinal organoids
Intestinal stem cells reside in a highly specialized niche at the 
base of crypts. It is, therefore, possible that this niche specifically 
allows stem cells to pause in an unlicensed G1 state in which ori-
gin licensing is prevented until a further proliferative-fate signal 
is received. To understand the contribution of the stem cell niche 
to the dynamics of entry and exit from the unlicensed G1 state, 
we used intestinal organoids, which allowed us to manipulate the 
stem cell niche/environment with small molecules. Although the 
distribution of licensed cells was similar between the branches of 
intestinal organoids and crypts in tissue, there were considerably 
more cells with DNA-bound Mcm2 in the former (Fig. 6, A and C 
[iii]). Importantly, cells in organoids showed a discrete peak of 
fully licensed G1 cells in addition to the cells in the unlicensed G1 
state (Fig. 6 B [ii]). This suggests that the epithelium in organ-
oids represents an accelerated state of self-renewal and may 
not fully recapitulate cell-cycle dynamics of intestinal epithelial 
cells in vivo.
We designed an assay to robustly assess licensing dynamics 
during entry and exit from the unlicensed G1 state and the tran-
sition toward G0. Specifically, we used flow cytometry–based 
quantification of DNA-bound Mcm2, Ki67, and DNA content to 
measure licensing dynamics during entry and exit from the unli-
censed G1 state and the transition toward G0 (Fig. S5 A). Most 
cells in organoids express Ki67, and it increased during cell- 
cycle progression (Fig. 6 B [i]). The DNA-bound Mcm2 profile was 
similar to that in isolated crypts (Fig. 6 B [ii]). Correlating Ki67 
and DNA-bound Mcm2 produced a distinctive profile that is sim-
ilar for isolated cells from organoids (Fig. 6 C [i]) and intestinal 
crypts (Fig. 6 C [ii]). This profile revealed a population of cells 
that appeared to lose Ki67 (Fig. 6 C [ii], dashed arrow) and may 
represent cells decreasing in proliferative capacity and transi-
tioning toward differentiation (Fig. S5 A). Such a loss of prolif-
erative capacity appeared to initiate in cells that expressed Ki67 
but were unlicensed, i.e., cells in unlicensed G1 phase. These data 
suggest that different stages of quiescence can exist, which are 
reflected by a spectrum of Ki67 and Mcm levels.
Stem-cell niche maintenance in organoids mainly depends 
on a combination of EGF, Wnt, and Notch signaling (Sato et al., 
2011). To identify the pathway that can modulate the unlicensed 
G1 state, we systematically treated organoids with a small mole-
cule inhibitor of EGF receptor (EGFR; gefitinib), a Wnt agonist 
(Chir99021), and a Notch activator (valproic acid). Short-term 
treatment with gefitinib, which reduces mitogen-activated pro-
tein kinase activity and blocks DNA replication and cell division 
(Lynch et al., 2004), immediately caused cells to accumulate in 
the unlicensed G1 state with a 2N DNA content, but they continued 
to express Mcm2 and Ki67 (Fig. 6, D and E). Only prolonged EGFR 
inhibition (4 d) caused a transition to an intermediate G0 state, 
with significantly reduced Ki67 expression but with total Mcm2 
levels maintained (Fig. 6, D and E). Both states were reversed by 
removal of EGFR inhibitors and addition of fresh EGFs (Fig. 6, D 
and E). Previously it was shown that EGFR increases Lgr5 expres-
sion (Basak et al., 2017), suggesting that these transitional states 
(unlicensed G1 and G0) are associated with “stemness.” Addition-
ally, EGFR inhibitors appeared to potently kill TA cells (Fig. S5, 
are pooled data from three mice. (F) Simulated ergodic-rate analysis of origin licensing during G1, with the licensing rate varied and a significant paused period 
incorporated (unlicensed G1). The displayed histograms show the frequency distribution of DNA-bound Mcm2 of G1 cells (n = 10,000). Please refer to Materials 
and methods for further information. However, an analogy to explain the model is as follows, as described in Matson et al. (2017): Origin licensing through G1 
can be thought of as cars traveling along a long stretch of motorway; if cars enter the motorway at a fixed rate (i.e., unsynchronized cell cycles, cells entering 
G1), the density of the cars at any one point is inversely proportional to the speed at which they are traveling (“speed” in this case means the rate of licensing). 
We have added the concept of delays at the start and end, like tollbooths. In our model, there is a minimum drive time (minimum length of G1 required for 
cells to grow to a critical size before they enter the S phase; arbitrarily set at 100%). If the speed of the cars means they don’t reach the end of the motorway 
before that time is up, cars maintain a constant speed along the entire road and exit the motorway as soon as they reach the end. If cars drive faster, and they 
reach the end before that time is up (>100%), they have to wait at the end of the motorway until the critical time has expired, resulting in a peak accumulation 
at the fully licensed point. Unlicensed G1 is an enforced time that cars have to wait once they enter the motorway before they are allowed to drive along it. 
This creates a peak on the left (unlicensed cells). If the cars then drive slowly, when they get to the end of the motorway, they exit immediately because the 
critical time has expired (center), but if they drive fast enough, they reach the end of the motorway before the critical time has expired. This results in a peak 
accumulation at both minimally and maximally licensed points. (G) Comparison of DNA-bound Mcm2 content of Lgr5+ and Lgr5− G1 cells and of cells in the very 
early S phase. Shown are pooled data from three mice.
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B and C), leaving branches containing only stem cells (Basak et 
al., 2017). This suggests that both the fully quiescent G0 and the 
unlicensed G1 states can provide protection to stem cells.
Treatment with the Wnt agonist Chir99021 did not appear 
to significantly affect licensing dynamics (Fig. S5 C). Strik-
ingly, treatment with valproic acid (a Notch activator) alone or 
Figure 5. LRCs are in a deep G0 state. (A) Labeling strategy. H2B–GFP expression was induced in all intestinal epithelial cells in H2B–GFP mice by adminis-
tration of doxycycline for 7 d. After complete labeling, doxycycline was removed, and mice rested for 7 d. During that chase period, most H2B–GFP+ cells are 
lost by label dilution because of cell division and upward migration. Both Paneth cells and +4 LRCs are H2B–GFP+ after the chase period. The +4 LRCs were 
distinguished from Paneth cells by the lack of UEA staining (Buczacki et al., 2013). (B) Representative images of whole-mount sections of H2B–GFP expressing 
small-intestine tissue after a 7-d labeling period (i). Bars, 100 µm. A vibratome section (ii) of intestinal tissue after a subsequent 7-d chase period, stained with 
Hoechst (nuclei), UEA (gray), and an antibody against Mcm2 (red). Bars, 50 µm. An enlarged image of the marked crypt is shown. Bar, 10 µm. A UEA− LRC is 
marked with a white arrow. Quantification of the mean GFP intensity for all cells along the crypt–villus axis is shown after the 7-d chase period (n = 3,525 cells 
(iii). (C) A representative image (i) of an LRC in an intestinal crypt stained with Hoechst (blue), UEA (white), and an antibody against Mcm2 (red). Bar, 10 µm. The 
LRCs (white arrows) do not express Mcm2. The quantification of Mcm2 expression in LRCs (n = 12), Paneth cells (n = 116), and all cells (n = 543) is shown (iii). 
(D) Representative images of extracted H2B–GFP crypts after the 7-d chase period. Bar, 10 µm. H2B–GFPHi cells (bright green) represent Paneth cells and +4 
LRCs (i), and H2B–GFPlow cells (faint green) represent daughter cells (white arrows) that have diluted H2B–GFP content because of cell division (ii). The quantifi-
cation of DNA-bound Mcm2 in GFPHi LRCs (n = 110) and GFPlow daughter cells (n = 186) compared with the total cell population (all cells; n = 3,236) is shown (iii).
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in combination with Chir99021 significantly altered licensing 
profiles (Fig. S5, D and F). The combination of Chir99021 and 
valproic acid induced Lgr5 expression throughout the organ-
oid epithelium (Fig. S5 E; Yin et al., 2014). Our data showed that 
this was associated with the appearance of a population of cells 
with low levels of Ki67 and intermediate levels of DNA-bound 
Mcm2 (Fig. S5 D), similar to the intermediate, unlicensed G1 state 
induced by EGFR inhibitors. Surprisingly, we observed an arc of 
Figure 6. Licensing dynamics in intestinal organoids. (A) Representative image of unextracted and extracted intestinal organoids stained with Hoechst 
(blue) and an antibody against Mcm2 (red) after a 1-h EdU pulse (green). Bars, 15 µm. (B) Representative flow cytometry profiles from isolated organoid cells 
showing Ki67 (i) or DNA-bound Mcm2 (ii) content versus DNA content. Data are representative of three independent experiments. (C) Representative flow 
cytometry profile from cells isolated from cultured organoids (i) or intestinal crypts (ii) showing DNA-bound Mcm2 versus Ki67 (Fig. S5 A). Ki67 loss and sub-
sequent loss of Mcm2 during differentiation is apparent, starting from unlicensed G1 (dashed arrow). Quantification of discrete populations (gates shown in 
i) was performed: (1) G0, (2) transition (G0 ↔ unlicensed G1), (3) unlicensed G1, and (4) licensed G1, (5) S phase, and (6) late S/G2/M (n = 3) with means ± SEM 
displayed. (D) Representative flow cytometry profiles of isolated organoid epithelial cells grown in ENR (control) and treated with the EGFR inhibitor gefitinib 
for the indicated times (i–iii). After 4 d in gefitinib, organoids were reactivated by removal of the gefitinib and readdition of fresh growth factors (ENR) for 
2 d (iv). Displayed are profiles comparing DNA-bound Mcm2 versus Ki67 (top) or total Mcm2 content (bottom). Data are representative of three independent 
experiments. (E) The G1 cell populations, as shown in D, were quantified. DNA-bound Mcm2 profiles (i) show (1) unlicensed G1, (2) licensed G1, (3) transition 
(G0 ↔ unlicensed G1), and (4) G0 populations. Total-Mcm2 profiles (ii) show Mcm2-expressing, i.e., Mcm2+, and nonexpressing, i.e., Mcm2−, cells (n = 3). Data 
are displayed as percentage means ± SEM.
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cells connecting this to the fully licensed state, suggesting that 
relicensing of these cells occurs before they express high levels 
of Ki67 and that cells can reactivate licensing from a deeper state 
of G0 directly (Fig. S5, D and F).
Inhibiting Notch signaling with DAPT (N-[N-(3,5-difluoro-
phenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester), which 
induces terminal secretory cell differentiation (van Es et al., 
2005), also significantly altered licensing dynamics and induced 
deep G0 with reduced Ki67 and loss of Mcm2 proteins (Fig. S5 G). 
Together, these data suggest that both EGFR and Notch signaling 
can significantly influence the licensing dynamics during the 
transition between quiescence and unlicensed G1.
The unlicensed-G1 state is lost in Apc mutant organoids
Many established cell lines appear to lack an unlicensed G1 state; 
instead, licensing of all origins occurs immediately upon mitotic 
exit (Friedrich et al., 2005; Håland et al., 2015; Moreno et al., 
2016; Matson et al., 2017). In addition, many of these cell lines 
lack a functional licensing checkpoint (Shreeram et al., 2002; 
Feng et al., 2003; Liu et al., 2009; Nevis et al., 2009), which has 
been suggested to arrest cells in G1 by inactivation of the RB-E2F 
restriction point (Shreeram et al., 2002; Machida et al., 2005; 
Teer et al., 2006; Liu et al., 2009; Nevis et al., 2009). To under-
stand the biological relevance of the unlicensed G1 state, we 
determined whether origin licensing dynamics during G1 were 
altered during the initial stages of tumorigenesis.
The first initiating mutations in colorectal cancer are usually 
in adenomatous polyposis coli (Apc). Therefore, we investigated 
whether licensing dynamics were altered in Apc-mutant intesti-
nal epithelium. In ApcMin/+ epithelium in vivo, Mcm2 expression 
appeared normal in areas of normal histology but was greatly 
increased in polyps (Fig. 7 A). In isolated ApcMin/+ crypts, there 
was a slight increase in the size of the proliferative compartment 
similar to that found in a previous study (Trani et al., 2014), and 
a slight increase in the number of EdU+ cells in the stem cell 
compartment (Fig. 7 B [i and iii]). However, in most crypts, there 
were no significant differences in the number or distribution of 
licensed cells in the stem-cell compartment (Fig. 7 B [i and iii]). 
However, we found a small number of crypts that were consid-
erably larger. Strikingly, within these crypts, we noticed small 
“ribbons” of EdU+ cells that extended significantly into the TA 
compartment (Fig. 7 B [ii]). We suspected that these ribbons rep-
resent clones of cells that had undergone loss of heterozygosity 
(LOH) and that continually reengage with the cell cycle. This, 
in turn, suggests that the LOH event that converts ApcMin/+ to 
ApcMin/Min cells significantly alters cell-cycle dynamics.
To determine whether LOH alters origin licensing dynam-
ics by modifying G1, we compared WT and ApcMin/Min organoids 
(Fig. 7 C). ApcMin/Min organoids contained many more licensed 
cells that were distributed randomly throughout the organoid 
(Fig. 7 D), reminiscent of the altered distribution of Ki67+ cells 
in these organoids (Fatehullah et al., 2013). Strikingly, we found 
that licensing dynamics in the G1 phase of ApcMin/Min cells were 
different, and there was a significant loss of the unlicensed G1 
population (Fig. 7 E). Instead, most cells appear to license imme-
diately upon G1 entry and progressed into S phase immediately 
after minimal licensing (Fig. 7, E and F). Nonetheless, we still 
detected a population of cells that licensed as many origins as 
cells in WT organoids. These may be residual ApcMin/+ cells that 
had not undergone LOH yet and thus maintained near-normal 
cell-cycle dynamics.
A functional licensing checkpoint depends on an intact Rb 
restriction point, and we tested whether the relative amounts 
of hypo- and hyperphosphorylated Rb varied between WT and 
ApcMin/Min epithelia. In WT organoids, we noticed that most of 
the Rb appeared hypophosphorylated (Fig. 7 G). In contrast, in 
ApcMin/Min organoids, at least half of the Rb appeared hyper-
phosphorylated, with at least threefold more phosphorylated Rb. 
Together, these data are consistent with the idea that cells exist 
in an unlicensed G1 state before passage through the restriction 
point and activation of E2F-driven transcription. In contrast, Apc 
mutant cells appear to have lost normal restriction-point control 
so that they have constitutively hyperphosphorylated Rb, allow-
ing them to completely bypass the unlicensed G1 state.
Discussion
The cell cycle of intestinal stem and TA cells is poorly understood. 
By comparing the total and DNA-bound Mcm2 in intact intestinal 
crypts, we provide new insights into how licensing and cell-cycle 
commitment are coupled in this tissue. We provide evidence that, 
after their final mitosis, TA cells do not license their replication 
origins and immediately exit the cell cycle. We show that many 
Lgr5+ stem cells spend most of the G1 phase in an unlicensed 
state, continually expressing Mcm2 and Ki67. In the unlicensed 
G1 phase, stem cells could be poised to respond to cues and prog-
ress past that restriction point to resume the cell division cycle.
Lgr5+ stem cells have a cell-cycle length greater than TA cells 
(Schepers et al., 2011). The biological relevance of this is cur-
rently unknown. The data presented here suggest a delay in ori-
gin licensing is a key feature of the prolonged cell cycle of Lgr5+ 
cells. Although ∼80% of Lgr5+ cells are thought to be continually 
proliferative and express high levels of both Ki67 (Basak et al., 
2014) and Mcm2, we found that most Lgr5+ cells reside in an unli-
censed state, with 2N DNA content and Mcm2 not bound to DNA. 
Because the licensed state defines proliferative-fate commitment 
(Blow and Hodgson, 2002), we suggest that these cells are tempo-
rarily paused in the G1 phase, continuing to express proliferative 
makers, such as Ki67 and Mcm2, but without fully committing to 
the cell cycle (Fig. 8). We show that the number of Lgr5+ cells with 
DNA-bound Mcm2 was similar to the number of proposed active 
stem cells determined in lineage-tracing experiments (Kozar et 
al., 2013; Baker et al., 2014).
Prolonged arrest may eventually result in degradation of 
MCM2–7 proteins and lead to induction of a state of deep qui-
escence (G0). Consistent with this idea, we observed that LRCs, 
thought to provide a reserve of quiescent stem cells, did not 
express Mcm2. The lack of Mcm2 expression may reflect that 
significant time has passed since those cells divided. The delay 
in activating the licensing system may create a prolonged time 
window for Lgr5+ cells to receive and interpret environmental 
cues before deciding to commit to duplication, offering a means 
to control their number. It is likely that most Lgr5+ cells regu-
larly resume their cell cycle, given their continual expression 
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Figure 7. Unlicensed G1 is lost in Apc mutant epithelium. (A) A representative vibratome section of ApcMin/+ intestinal epithelium stained with Hoechst 
(nuclei), phalloidin, and an antibody against Mcm2. Bar, 200 µm. Regions of normal histology and a region containing a polyp are highlighted. (B) Representative 
image of an extracted ApcMin/+ isolated crypt (i) stained with Hoechst (nuclei) and an antibody against Mcm2 (red) after a 1-h EdU pulse (green). A representa-
tive image of an abnormally elongated crypt is displayed (ii) showing a clonal ribbon of cells in the distal TA compartment, which are EdU+. Quantification of 
cell-cycle stages across the crypt axis (Fig. 3) is shown (iii; n = 40 crypts). Bars, 10 µm. (C) Representative bright-field images of organoids cultured from WT 
and ApcMin/+ mice that have undergone LOH (ApcMin/Min). Bars, 50 µm. (D) Representative images of unextracted and extracted ApcMin/Min organoids stained 
with Hoechst (nuclei) and an antibody against Mcm2 (red) after a 1-h EdU pulse. Bars, 50 µm. (E) Representative flow cytometry profiles from cells of extracted 
WT and ApcMin/Min organoids showing DNA-bound Mcm2 versus DNA content (i). The 2N G1 cells of the profile shown are displayed (ii), showing unlicensed G1, 
early G1, and peak (fully licensed) G1 populations. Data are representative of three independent experiments. (F) Quantification of the populations described in 
E(ii). Data are displayed as means ± SEM (n = 3 organoids. (G) Western blot of Rb and pRb (low and high exposure) levels between WT and ApcMin/Min organoids. 
Two bands, corresponding to hypo- and hyperphosphorylated Rb, are shown. (H) Quantification of the fold increase of pRb:Rb for ApcMin/Min organoids (n = 3) 
and polyps isolated from ApcMin/+ mice (n = 6), compared with WT organoids and tissue.
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of proliferation markers (Basak et al., 2014). The identity and 
decisions of Lgr5+ cells are governed by stochastic choices, and 
the ability to pause briefly in G1 offers them unique flexibility in 
making those choices.
As expected, the transition from unlicensed G1 to licensed G1 
seems dependent on EGFR signaling. However, other pathways 
responsible for stem-cell maintenance can also significantly 
cause the appearance of a unique population of unlicensed cells 
with distinct cell-cycle dynamics. Growing evidence suggests 
that intestinal stem-cell fate is not governed by asymmetric seg-
regation of fate determinants (Lopez-Garcia et al., 2010; Snippert 
et al., 2010; Steinhauser et al., 2012). Instead, factors operating 
in the stem-cell niche, such as Wnt and Notch signaling, affect 
stem-cell fate decisions and also reduce the cycle rate of intes-
tinal stem cells (Hirata et al., 2013). This is consistent with the 
idea that cell-fate choices are affected by decreasing prolifera-
tion rates and increasing G0/G1 length. Indeed, extending G1 in 
mouse and human embryonic stem cells can drive differentia-
tion (Calder et al., 2013; Coronado et al., 2013). Similarly, long 
G1 phases are associated with the generation of fate-restricted 
progenitors during neurogenesis (Arai et al., 2011). An extended 
time window in the cell cycle has been suggested to allow niche 
factors and/or fate determinants to accumulate to direct pro-
genitor fate (Calegari and Huttner, 2003). In the case of adult 
intestinal stem cells, holding cells in G1 may allow an extended 
time for stem-cell fate factors to act and maintain stem-cell fate. 
In contrast, many embryonic stem cells license rapidly, and the 
cell cycle slows throughout differentiation (Matson et al., 2017).
However, similar to embryonic stem cells (Ge et al., 2015), 
intestinal stem cells appear to have licensed more origins than 
non–stem cells have when they enter the S phase. This may 
help ensure accurate and complete genome duplication in long-
lived stem cells (Moreno et al., 2016). With a greater demand 
for licensed origins, intestinal stem cells may, therefore, more 
readily engage the licensing checkpoint that ensures that all 
origins are licensed before cells enter the S phase (Shreeram 
et al., 2002; Liu et al., 2009; Alver et al., 2014). This additional 
demand for licensed origins in stem cells may also explain why 
crypts that are hypomorphic for Mcm2 have stem-cell deficien-
cies (Pruitt et al., 2007).
It is unclear how intestinal stem cells enter a significant, unli-
censed G1 state. The simplest explanation is that licensing factors, 
Figure 8. Model of origin licensing dynamics in intestinal epithelial cells. In a normal cell cycle, the Mcm cells are expressed ubiquitously in all stages. 
The licensing of DNA with MCM2–7 occurs in late M and throughout G1, when a cell receives a stimulus to commit to the cell cycle. As DNA is replicated during 
the S phase, MCM2–7 are displaced from DNA and are prevented from relicensing in G2. During terminal differentiation, MCM2–7 are not actively transcribed, 
and the proteins are gradually lost in postmitotic cells. However, after the final mitotic division, cells make a binary decision never to license their DNA, even 
though the protein is still present. Mcm proteins then degrade slowly, where cells enter a terminally differentiated state (deep G0). Alternatively, cells can exit 
mitosis, not relicense their DNA but maintain proliferative markers, and disengage from the cell cycle for some time (unlicensed G1). Two major classes of intes-
tinal stem cells exist: “active” stem cells, engaged with the cell cycle, and reserve, quiescent LRCs. LRCs are in a state of “deep” quiescence and do not contain 
MCM2–7 because they have disengaged from the cell cycle for some time. In this study, we show that most active Lgr5+ stem cells reside in an unlicensed state 
but contain MCM2–7 proteins. These cells reside in an unlicensed G1 phase until they make a proliferative-fate decision, enter the cell cycle, and license. This 
provides an explanation for the elongated cell cycle of intestinal stem cells; they reside in a partial resting state in which they may be able to respond to niche 
cues to divide. This, therefore, may constitute a unique mechanism to control stem cell numbers.
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such as Cdt1 or Cdc6, are not readily available in new-born stem 
cells, and their synthesis has to be stimulated by an upstream 
signal for fate commitment via activation of E2F-driven tran-
scription. This is the situation after prolonged quiescence, 
which is accompanied by passive down-regulation of licensing 
factors (Coller, 2007). In contrast, in continually dividing cells, 
their levels are maintained. Consistent with this idea, licensing 
factors such as Cdc6, along with many cyclin-dependent kinase 
complexes, are down-regulated beyond the end of the TA zone 
(Frey et al., 2000; Smartt et al., 2007). Cells without a functional 
restriction point, such as Apc mutant cells or most cancer cell 
lines, could immediately license their origins upon entering G1 
and can progress into S phase without sufficient origins being 
licensed. Interestingly, both TA cells and highly proliferative Apc 
mutant cells are very sensitive to replication inhibitors, such as 
gefitinib (Fig. S5 H). WT stem cells survive this treatment, poten-
tially by engaging the licensing checkpoint to reversibly stall 
in the unlicensed G1 phase. This suggests that the unlicensed 
G1 phase can protect stem cells from replication inhibitors and 
offers researchers a potentially selective means to kill highly pro-
liferative cells, such as Apc mutant cells (Shreeram et al., 2002; 
Blow and Gillespie, 2008).
In summary, we demonstrate that the dynamics of the DNA 
replication licensing system provides a new way for measuring 
the proliferative fate of intestinal stem cells. We suggest a model 
for “working” intestinal stem cells that spend a significant pro-
portion of the G1 phase in an unlicensed state until a prolifer-
ative-fate decision is made. Correspondingly, exit from the cell 
cycle in +4 LRCs leads to loss of proliferative capacity and loss 
of Mcm2 expression causing cells to enter a deeply G0 quiescent 
state (Fig. 6). The unlicensed G1 state is lost in Apc mutant epi-
thelia, which lack a functional Rb-restriction point. We suggest 
that the unlicensed G1 state serves stem cells in controlling their 
numbers by regulating the cell cycle.
Materials and methods
Mice
All experiments were performed under UK Home Office guide-
lines. CL57BL/6 (WT), R26-rtTA Col1A1-H2B-GFP (H2B–GFP), 
Lgr5-EGFP-IRES-creERT2 (Lgr5GFP/+), and ApcMin/+ mice were 
sacrificed by cervical dislocation or CO2 asphyxiation. Fucci2aR 
mice (Mort et al., 2014) were a gift from R. Mort (University of 
Edinburgh, Edinburgh, Scotland, UK).
Tissue preparation: whole small intestine
Dissected pieces of adult-mouse small intestine were washed 
briefly in PBS and then fixed in 4% PFA for 3 h at 4°C. Intestines 
were cut into 2 × 2-cm2 pieces and fixed overnight in 4% PFA at 
4°C. Tissue was embedded in 3% low–melting-temperature aga-
rose and cut into 200-µm sections with a Vibratome (Leica Bio-
systems). Sections were washed in PBS, permeabilized with 2% 
Triton X-100 for 2 h, and incubated with blocking buffer (1% BSA, 
3% normal goat serum, and 0.2% Triton X-100 in PBS) for 2 h at 
4°C. Tissue was incubated in working buffer (0.1% BSA, 0.3% 
normal goat serum, and 0.2% Triton X-100 in PBS) containing 
primary antibody Mcm2 (1:500; Cell Signaling Technology) for 
48 h at 4°C. Sections were washed five times with working buf-
fer before 48-h incubation with secondary antibodies diluted in 
working buffer: Alexa Fluor–conjugated goat anti–rabbit (1:500; 
Molecular Probes) plus 5 µg/ml Hoechst 33342 and Alexa Fluor–
conjugated phalloidin (1:150; Molecular Probes). Sections were 
mounted on coverslips in ProLong Gold (Thermo Fisher Scien-
tific) between 2 × 120-µm spacers.
Tissue preparation
Isolating and staining crypts
Small intestines were dissected, washed in PBS and opened lon-
gitudinally. Villi were removed by repeated (≤10 times) scraping 
of the luminal surface with a coverslip. Tissue was washed in PBS 
and incubated in 30 mM EDTA (25 min at 4°C), and crypts were 
isolated by vigorous shaking in PBS. Crypt suspensions were cen-
trifuged (fixed rotor, 88 relative centrifugal force, 4°C), and the 
pellet was washed twice in cold PBS. Crypts were fixed in 4% PFA 
(30 min at room temperature), permeabilized in 1% Triton X-100 
(1 h at room temperature), and blocked in blocking buffer (2 h at 
4°C). Crypts were incubated with primary antibodies diluted in 
working buffer: Mcm2 (1:500; Cell Signaling Technology), phos-
po-Histone H3 (1:500; Abcam), Ki67 (1:250, ab15580; Abcam), 
and αGFP (1:500; Abcam); washed five times with working buffer, 
before overnight incubation with secondary antibodies diluted in 
working buffer: Alexa Fluor–conjugated goat anti–mouse or anti–
rabbit (1:500; Molecular Probes); or stains: rhodamine-labeled 
UEA I (1:500), 5 µg/ml Hoechst 33342, or Alexa Fluor–conjugated 
phalloidin (1:150) at 4°C. Crypts were mounted directly on slides 
in ProLong Gold overnight.
Cytoskeleton buffer extraction of isolated crypts
Soluble proteins were extracted from crypts isolated as described 
above by incubation with cytoskeleton extraction buffer (10 mM 
Hepes, 100 mM NaCl, 3 mM MgCl2, 1 mM EGTA, 300 mM sucrose, 
0.2% Triton X-100, 1  mM DTT, and 2% BSA) supplemented 
with protease inhibitors (PMSF, pepstatin, leupeptin, cystatin, 
Na3VO4, NaF, and aprotinin) for 20 min on ice before fixation. 
Crypts were then fixed with 4% PFA and processed for imaging 
as described above.
H2B–GFP label retention
H2B–GFP expression in transgenic R26-rtTA Col1A1-H2B-GFP 
mice was induced by replacing normal drinking water with 5% 
sucrose water supplemented with 2 mg/ml doxycycline. After 7 
d, doxycycline water was replaced with normal drinking water. 
Subsequently, mice were sacrificed after 7 d.
EdU incorporation and detection
Mice were injected i.p. with 100 µg EdU (Thermo Fisher Scien-
tific) prepared in 200-µl sterile PBS. Mice were sacrificed 1 h 
or 17 h after induction. For organoids, 10 µM EdU was included 
in crypt medium for 1 h before harvesting. EdU was detected 
by Click-it chemistry (Thermo Fisher Scientific) by incuba-
tion in EdU working buffer (1.875 µM Alexa Fluor 488 azide; 
Thermo Fisher Scientific), 2  mM CuSO4, and 10  mM ascor-
bic acid overnight at 4°C before processing for immunofluo-
rescence staining.
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Organoid culture
Isolated crypts were dissociated to single cells with TripLE 
express (Thermo Fisher Scientific) at 37°C for 5 min. Dissoci-
ated cells were filtered through a 40-µm cell strainer (Greiner 
Bio-One) and suspended in growth factor–reduced Matrigel 
(BD Biosciences). Organoids were grown in crypt medium 
(advanced DMEM/F12 [ADF] supplemented with 10  mM 
Hepes, 2 mM Glutamax, 1 mM N-acetylcysteine, N2 [Gemini 
Bio Products], B27 [Thermo Fisher Scientific], and penicil-
lin/streptomycin [MilliporeSigma]) supplemented with EGF/ 
Noggin/R-spondin 1 (ENR) medium (50 ng/ml EGF [Thermo 
Fisher Scientific], 100 ng/ml Noggin [Thermo Fisher Scien-
tific], and R-spondin–conditioned media) produced from sta-
bly transfected L cells (1:4). Chiron99021 (3 µM), valproic acid 
(1 mM; Thermo Fisher Scientific), and Y27632 (10 µM; Thermo 
Fisher Scientific) were added to the culture for the first 48 h. 
Organoids were passaged every 3–5 d by mechanically disrupt-
ing Matrigel and by washing and pipetting in ADF. Dissociated 
crypts were resuspended in fresh Matrigel and grown in crypt 
medium supplemented with EGFs.
For small-molecule treatments, primary intestinal epithelial 
cells were cultured in ENR plus Chiron99021, valproic acid, and 
Y27632 for 3 d, and then, organoids were subcultured in ENR 
for an additional 2 d before the start of the experiment. Organ-
oids were then treated with the stated small molecules for the 
indicated times. For induction of unlicensed G1, organoids were 
treated with gefitinib (5 µM), coupled with removal of EGF from 
the crypt medium. For the reactivation/chase period, the medium 
was removed and fresh EGFs were added. All EGFs and inhibitors 
were replenished every 2 d throughout the experiment.
Flow cytometry and cell sorting
Intestinal crypts were isolated and dissociated to single cells 
as described above. Isolated cells were filtered through 40-µm 
cell strainers (Greiner Bio-One). After one PBS wash, organoids 
were dissociated to single cells by incubation in TrypLE Express 
(Thermo Fisher Scientific) for 15 min at room temperature, 
followed by manual disruption by pipetting. Cells were then 
extracted with cytoskeleton buffer for 20 min on ice, followed by 
fixation in 0.5% PFA (pH 7.40 for 15 min at room temperature). 
Cells were then washed once in 1% BSA and permeabilized with 
ice-cold 70% EtOH for 10 min. Cells were then washed in 1% BSA 
and resuspended with primary antibodies (Mcm2, 1:500; GFP, 
1:500; and Ki67, 1:200) diluted in working buffer overnight at 
4°C). After two washes in working buffer, cells were resuspended 
in secondary antibodies goat anti–mouse or anti–rabbit (Alexa 
Fluor 647 [1:500; Molecular Probes] or Alexa Fluor 488–Ki67 
[1:400, clone SolA15; BD Biosciences]), diluted in working buffer 
(1 h at room temperature). After two washes in 1% BSA, cells were 
suspended in working buffer containing 15 µg/ml DAPI. Samples 
were analyzed on an FACS Canto (BD Biosciences).
For cell sorting, cells were isolated from Lgr5–GFP mice as 
described above by treatment with TrypLE Express for 15 min 
at 37°C, followed by filtration through 40-µm filters (Greiner 
Bio-One). Cells were sorted in ADF supplemented with 1% FBS 
and DAPI (15 µg/ml). Sorting was performed with an Influx cell 
sorter (BD Biosciences). Cells were checked after being sorted 
to ensure sample purity by reexamining Lgr5 expression in 
the sorted gates.
Microscopy and image analysis
Samples were imaged with an LSM 710 microscope (Carl Zeiss) 
with 25×/0.8 NA and 40×/1.3 NA LD Plan-Neofluar objective 
lenses and immersion oil with a refractive index of 1.516. Z stacks 
were acquired at optimal-section intervals between 0.3 and 0.8 
µm at room temperature with Zen 2011 acquisition software 
(Carl Zeiss). All fixed samples were mounted in ProLong Gold. 
For quantification, images were acquired at 16 bit-depth.
Image processing and analysis were performed with Imaris 
software (Bitplane). Images of individual crypts were manually 
cropped, ensuring that an individual crypt was the only region 
of interest. All nuclei were detected in individual crypts with 
automated thresholding in Imaris, with the measurement-point 
function set to detect nuclei at an estimated size of 3.5 µm. 
Missed or incorrectly assigned nuclei were manually identified. 
This function produced measurement points that segmented the 
specific region at the corresponding coordinate of the measure-
ment point. Mean intensities for different channels were calcu-
lated per spot. This equates to the intensity at the center region 
of each nucleus. A reference nucleus at the crypt base was used 
to define the crypt-base position. The Euclidean distance to that 
point was measured and defined as the distance to the crypt base. 
Multiple images were analyzed with the same workflow, and the 
analyzed files were collated. For vibratome sections, a plane was 
manually defined running through to the muscle layer beneath 
the epithelium. The smallest distance to that surface was defined 
for segmented nuclei. For nuclear-volume estimation, the nuclei 
were manually segmented in 3D with the manual segmentation 
tools within Imaris (Fig. S1).
Flow cytometry analysis
Flow cytometry data were analyzed with FlowJo software (Tree 
Star) and a standardized gating strategy (Fig. S1). In brief, cells 
were identified by forward and side light scatter. After doublet 
discrimination, gates were set with appropriate controls lacking 
conjugated secondary antibodies and without primary antibod-
ies. Mcm2-negative gates were set by secondary-only controls in 
conjunction with the Mcm2 intensity of G2 cells. G1 cells were 
discriminated based on the maximal DNA-bound Mcm2 intensity 
before the S phase and by DAPI intensity.
Computational modeling
A deterministic computer model for licensing in G1 was writ-
ten in the Swift programming language (Apple) in the Xcode 9 
development environment. The model assumes that there is a 
minimum G1 period that is required for cells to grow to a crit-
ical size before they can enter the S phase. Licensing can take 
place during that period at a constant rate. A licensing rate of 1 
means that cells will be fully licensed in exactly the minimum 
G1 period. It was also assumed that cells had a robust “licensing 
checkpoint” (Shreeram et al., 2002; Blow and Gillespie, 2008), 
so that they could not enter the S phase until the origins have 
been fully licensed. An optional “unlicensed G1 period” occurred 
at the start of G1; during which time, no licensing takes place. In 
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the simulation, cells enter G1, wait for any optional “unlicensed 
G1 period,” then start to license origins at a fixed rate; cells exit 
G1 and modeling ceases only when they have become maximally 
licensed and the minimum G1 period had elapsed. The model 
divided the minimum G1 period into 10,000 equal steps and 
recorded the degree of licensing at the end of each step in the 
licensing array. The contents of the licensing array were dis-
tributed into 101 different frequency bins, ranging from 0 (no 
licensing) to 100% (maximal licensing). To model the background 
signal recorded by flow cytometry, all the licensing values were 
increased by 5%. To model the flow cytometry measurement 
error, the frequency array was smoothed by starting at the small-
est bin and pushing 80% of the cell counts into the next largest 
bin and, then, starting at the largest bin, pushing 80% of the cell 
counts into the next-smallest bin.
Online supplemental material
Fig. S1 illustrates the image-analysis workflow used to measure 
licensing dynamics along the crypt axis and describes the flow 
cytometry gating strategy. Fig. S2 shows the clonal cell-cycle field 
effects reflected by neighboring cells along the crypt axis with 
similar licensing and replication profiles, and the flow cytom-
etry and nuclear volume measurements are used to show that 
intestinal stem cells have a normal cell-cycle distribution and are 
not all in the G2 phase of the cell cycle. Fig. S3 shows the ubiqui-
tous expression of Ki67 along the crypt axis. Fig. S4 examines 
the expression of the fluorescence ubiquitination cell-cycle indi-
cator and reporters in the intestinal epithelium, showing that 
most stem cells express little of the G1 hCdt1(30/120) marker, 
consistent with an unlicensed G1 phase. Fig. S5 shows the licens-
ing dynamics in the intestinal organoids with altered stem cell–
niche signaling. This revealed that (a) the combination of Ki67 
and DNA-bound Mcm2 is a robust means of exploring cell-cycle 
dynamics during transitions to quiescence, (b) Chir99021 and 
valproic acid treatments induce unique cell-cycle dynamics, and 
(c) ApcMin/Min organoids are sensitive to gefitinib, whereas WT 
organoids are not. Video 1 shows cell-cycle clones. We also include 
the source code used for the simulations of licensing through G1.
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